AP Biosciences Inc (6945.TWO)
TWD 39.6
(-23.55%)
TWD 39.6
(-23.55%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 32.25 Million TWD | 27.64% |
| 2022 | 297.49 Million TWD | 53.58% |
| 2021 | 193.71 Million TWD | 209218.91% |
| 2020 | 92.54 Thousand TWD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 116.68 Million TWD | 2.05% |
| 2024 Q1 | 114.34 Million TWD | -11.36% |
| 2023 Q4 | 128.99 Million TWD | 0.0% |
| 2023 FY | 379.73 Million TWD | 27.64% |
| 2023 Q3 | 128.99 Million TWD | 110.8% |
| 2023 Q2 | 61.19 Million TWD | 0.0% |
| 2023 Q1 | 61.19 Million TWD | -4.75% |
| 2022 FY | 297.49 Million TWD | 53.58% |
| 2022 Q4 | 64.24 Million TWD | 0.0% |
| 2022 Q3 | 64.24 Million TWD | 0.0% |
| 2021 FY | 193.71 Million TWD | 209218.91% |
| 2020 FY | 92.54 Thousand TWD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | 329 Thousand TWD | -9703.343% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 127.67 Million TWD | 74.737% |
| Level Biotechnology Inc. | 151.99 Million TWD | 78.78% |
| Sagittarius Life Science Corp | 135.85 Million TWD | 76.259% |
| NeoCore Technology Co., Ltd. | 75.85 Million TWD | 57.483% |
| TaiMed Biologics Inc. | 225.23 Million TWD | 85.68% |
| GlycoNex Incorporation | 995 Thousand TWD | -3141.508% |
| VBI | 32.55 Million TWD | 0.928% |
| GeneReach Biotechnology Corp. | 256.86 Million TWD | 87.444% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 194.18 Million TWD | 83.391% |
| SynCore Biotechnology Co.,Ltd | 46.02 Million TWD | 29.92% |
| Genomics BioSci & Tech. Co.,Ltd. | 119.91 Million TWD | 73.102% |
| Visgeneer Inc. | 67.48 Million TWD | 52.205% |
| Mycenax Biotech Inc. | -375.19 Million TWD | 108.596% |
| Sunmax Biotechnology Co., Ltd. | 510.09 Million TWD | 93.677% |
| G&E Herbal Biotechnology Co., Ltd. | 63.9 Million TWD | 49.528% |
| Neith Corporation | 66.87 Million TWD | 51.77% |
| Medigen Vaccine Biologics Corporation | 1.44 Billion TWD | 97.766% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 29.35 Million TWD | -9.883% |
| Enimmune corporation | 220.1 Million TWD | 85.346% |
| TaiRx, Inc. | 217.13 Million TWD | 85.146% |
| CHO Pharma, Inc. | 268.99 Million TWD | 88.01% |
| EirGenix Inc. | 236.74 Million TWD | 86.376% |
| BioLASCO Taiwan Co., Ltd. | 104.35 Million TWD | 69.092% |
| Sunny Pharmtech Inc. | 357.62 Million TWD | 90.981% |
| Lin BioScience, Inc. | 1.09 Billion TWD | 97.059% |
| BioGend Therapeutics Co., Ltd. | 266.15 Million TWD | 87.882% |
| Feng Chi Biotech Corp. | 49.47 Million TWD | 34.804% |
| Bio Preventive Medicine Corp. | 1.08 Million TWD | -2878.116% |
| Lukas Biomedical Inc. | 177.45 Million TWD | 81.824% |
| RBC Bioscience Corporation | 58.35 Million TWD | 44.731% |
| BiOptic Inc. | 108.69 Million TWD | 70.326% |
| BRIM Biotechnology, Inc. | 90 Thousand TWD | -35736.667% |
| Shine-On BioMedical Co.,Ltd. | 69.35 Million TWD | 53.492% |
| Great Novel Therapeutics Biotech & Medicals | 2.61 Million TWD | -1133.384% |
| Syngen Biotech Co.,Ltd. | 643.91 Million TWD | 94.991% |
| Advagene Biopharma Co., Ltd. | 93.33 Million TWD | 65.444% |
| NaviFUS Corp. | 11.82 Million TWD | -172.707% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 190.72 Million TWD | 83.09% |
| Sinew Pharma Inc. | 186.25 Million TWD | 82.683% |
| Andros Pharmaceuticals Co.,Ltd | 74.02 Million TWD | 56.428% |
| Greenyn Biotechnology Co., Ltd | 220.39 Million TWD | 85.366% |
| Lumosa Therapeutics Co., Ltd. | 41.48 Million TWD | 22.246% |
| Medigen Biotechnology Corp. | 1.85 Billion TWD | 98.257% |
| 3D Global Biotech Inc. | 5.27 Million TWD | -511.547% |
| Pharmosa Biopharm Inc. | 317.32 Million TWD | 89.836% |
| Intech Biopharm Corporation | -163.99 Million TWD | 119.667% |
| Oneness Biotech Co., Ltd. | 1.12 Billion TWD | 97.144% |
| Eusol Biotech Co.,Ltd. | 41.48 Million TWD | 22.248% |
| TWi Biotechnology, Inc. | 169.55 Million TWD | 80.978% |
| Ever Supreme Bio Technology Co., Ltd | 147.02 Million TWD | 78.062% |
| TCI GENE Inc. | 174.61 Million TWD | 81.529% |
| MegaPro Biomedical Co., Ltd | 18 Thousand TWD | -179083.333% |
| Senhwa Biosciences, Inc. | 300.93 Million TWD | 89.283% |
| Taiwan Bio Therapeutics Co., Ltd | 290.95 Million TWD | 88.915% |
| NatureWise Biotech & Medicals Corporation | 83.94 Million TWD | 61.578% |
| PharmaEngine, Inc. | 441.78 Million TWD | 92.699% |
| Savior Lifetec Corporation | 223.36 Million TWD | 85.561% |
| TaiGen Biopharmaceuticals Holdings Limited | 258.77 Million TWD | 87.536% |
| OBI Pharma, Inc. | 2.01 Billion TWD | 98.4% |
| Meribank Biotech Co., Ltd | 138.87 Million TWD | 76.775% |
| Acepodia, Inc. | 452.56 Million TWD | 92.873% |
| Caliway Biopharmaceuticals Co., Ltd. | 540.93 Million TWD | 94.038% |